Conducting pharmaceutical R&D in India - Critical components of entry strategies.
In the face of challenges associated with expiring patents, the rising cost of R&D and pressure on pricing, most major pharmaceutical companies are seeking ways to enhance productivity, reduce costs and augment the late-stage new-product pipeline. Exploiting the R&D capabilities in India is one option that can be helpful in achieving these goals. However, considering the challenges involved, important considerations must be incorporated to ensure that an appropriate R&D strategy is meticulously implemented. In creating suitable strategies, it is important to understand the historical perspective that provides insight into the relative strengths of companies in India across the R&D value chain. In addition, the ability of a company to take risks and commit to a long-term investment will largely determine the model that is selected. To implement a given model, an understanding of cultural differences and infrastructural challenges that must be overcome is extremely important. The ultimate factor that determines success or failure, however, lies within the organization. Preparing an organization by establishing appropriate structures and processes is imperative.
Gulati
Rajiv
R
DC - 1083, Eli Lilly & Co, Lilly Corporate Center, Indianapolis, IN 46285, USA. r.gulati@lilly.com
D000818:Animals; D004345:Drug Industry / Q000191:economics / Q000266:history / Q000639:trends*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007194:India; D012106:Research / Q000191:economics / Q000639:trends*